Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Total Non-Current Liabilities (2022 - 2026)

HeartSciences (HSCS) has disclosed Total Non-Current Liabilities for 4 consecutive years, with $247263.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities fell 45.99% year-over-year to $247263.0, compared with a TTM value of $247263.0 through Oct 2025, down 45.99%, and an annual FY2025 reading of $314527.0, down 27.54% over the prior year.
  • Total Non-Current Liabilities was $247263.0 for Q4 2025 at HeartSciences, down from $281570.0 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $4.7 million in Q2 2022 and bottomed at $247263.0 in Q4 2025.
  • Average Total Non-Current Liabilities over 4 years is $966183.1, with a median of $486885.0 recorded in 2023.
  • Peak annual rise in Total Non-Current Liabilities hit 7.19% in 2023, while the deepest fall reached 73.82% in 2023.
  • Year by year, Total Non-Current Liabilities stood at $549227.0 in 2022, then dropped by 11.35% to $486885.0 in 2023, then decreased by 5.97% to $457814.0 in 2024, then crashed by 45.99% to $247263.0 in 2025.
  • Business Quant data shows Total Non-Current Liabilities for HSCS at $247263.0 in Q4 2025, $281570.0 in Q3 2025, and $314527.0 in Q2 2025.